A Randomized Trial to Assess the Acceleration of Viral Clearance by the Combination Favipiravir/Ivermectin/Niclosamide in Mild-to-Moderate COVID-19 Adult Patients (FINCOV)
Siripongboonsitti et al., Journal of Infection and Public Health, doi:10.1016/j.jiph.2024.03.030
https://c19early.org/siripongboonsitti6nc.html